ArticleFrontiers in medicine2023
A hybrid neural network approach for classifying diabetic retinopathy subtypes.
Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 16 citations in OpenAlex.
- Hybrid deep ensemble architecture for robust diabetic retinopathy classification: leveraging transfer learning and CNN-transformer synergy.Scientific reports · 2026Article
- Advanced retinal disease detection using RHT-Net: a hybrid deep learning approach with augmented fundus imaging.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Diabetic retinopathy is a prevalent complication among diabetic patients that, if not predicted and treated promptly, can lead to blindness. This paper proposes a method for accurately and swiftly predicting the degree of diabetic retinopathy using a hybrid neural network model. Timely prediction of diabetic retinopathy is crucial in preventing blindness associated with this condition. Methods: This study aims to enhance the prediction accuracy of diabetic retinopathy by utilizing the hybrid neural network model EfficientNet and Swin Transformer. The specific methodology includes: (1) combining local and global features to accurately capture lesion characteristics by leveraging the strengths of both Swin Transformer and EfficientNet models; (2) improving prediction accuracy through a comprehensive analysis of the model's training details and applying data augmentation techniques such as Gaussian blur to enhance the hybrid model's performance; (3) validating the effectiveness and utility of the proposed hybrid model for diabetic retinopathy detection through extensive experimental evaluations and comparisons with other deep learning models. Results: The hybrid model was trained and tested on the large-scale real-world diabetic retinopathy detection dataset APTOS 2019 Blindness Detection. The experimental results show that the hybrid model in this paper achieves the best results in all metrics, including sensitivity of 0.95, specificity of 0.98, accuracy of 0.97, and AUC of 0.97. The performance of the model is significantly improved compared to the mainstream methods currently employed. In addition, the model provides interpretable neural network details through class activation maps, which enables the visualization of diabetic retinopathy. This feature helps physicians to make more accurate diagnosis and treatment decisions. The model proposed in this paper shows higher accuracy in detecting and diagnosing diabetic retinopathy, which is crucial for the treatment and rehabilitation of diabetic patients. Conclusion: The hybrid neural network model based on EfficientNet and Swin Transformer significantly contributes to the prediction of diabetic retinopathy. By combining local and global features, the model achieves improved prediction accuracy. The validity and utility of the model are verified through experimental evaluations. This research provides robust support for the early diagnosis and treatment of diabetic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.